Prevalence and Correlates of Symptoms of Cannabinoid Hyperemesis Syndrome in the United States

A small but significant number of US adults with daily cannabis use reported symptoms consistent with CHS. Beyond patterns of cannabis use, those with CHS symptoms had fewer economic resources and endorsed more cannabis-related problems, even when compared to others with daily cannabis use. Most people reporting CHS symptoms were not diagnosed by a medical provider, suggesting that there may be a substantial cohort who is experiencing CHS symptoms but is not seeking medical treatment or having their condition recognized by medical providers. As cannabis use increases, it is likely that CHS will also become more common, underscoring the importance of expanded research on this condition.

Authors

Institutions

Publication Details

Journal
medRxiv
Published
2026-01-26
DOI
https://doi.org/10.64898/2026.01.25.26344780
Citations
2
Primary Topic
Cannabis and Cannabinoid Research
Type
article
Field-Weighted Citation Impact
65.15

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prevalence and Correlates of Symptoms of Cannabinoid Hyperemesis Syndrome in the United States

Amanda M. Price, Paula Goldman, Mark Andrew Ilgen, Brian M. M. Hicks
2 citations
medRxiv
Cannabis and Cannabinoid Research
65.15
article

Prevalence and Correlates of Symptoms of Cannabinoid Hyperemesis Syndrome in the United States

Amanda M. Price, Paula Goldman, Mark Andrew Ilgen, Brian M. M. Hicks
article en
2 citations

Abstract

A small but significant number of US adults with daily cannabis use reported symptoms consistent with CHS. Beyond patterns of cannabis use, those with CHS symptoms had fewer economic resources and endorsed more cannabis-related problems, even when compared to others with daily cannabis use. Most people reporting CHS symptoms were not diagnosed by a medical provider, suggesting that there may be a substantial cohort who is experiencing CHS symptoms but is not seeking medical treatment or having their condition recognized by medical providers. As cannabis use increases, it is likely that CHS will also become more common, underscoring the importance of expanded research on this condition.

medRxiv
University of Michigan (US), VA Center for Clinical Management Research (US), Department of Veterans Affairs (AU)
U.S. Department of Veterans Affairs, National Institutes of Health, National Institute of Mental Health
No poverty
Openalex Percentile: Top 0%
Cannabis and Cannabinoid Research
65.15
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.